SCHEMBL22372044

SCHEMBL22372044

CNC(=O)C(N)(OC)c1ccccc1COc1cc(C)ccc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.42
▸ PPARA Q07869 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ CYP2C9 P11712 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ PTGDR2 Q9Y5Y4 1/20 0.40
▸ TSHR P16473 2/20 0.40
▸ FFAR1 O14842 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ TDP1 Q9NUW8 3/20 0.39
▸ TTR P02766 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C8 P10632 1/20 0.39
▸ CHRM1 P11229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7524483 0.87 PPARA (0.44) SMN1; SMN2ALDH1A1PPARAMEN1KMT2A
SCHEMBL17715753 0.86 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1PPARAMEN1KMT2A
SCHEMBL27437488 0.77 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1PPARAMEN1KMT2A
SCHEMBL28084205 0.76 CYP2C9 (0.47) SMN1; SMN2ALDH1A1PPARAMEN1KMT2A
SCHEMBL18241048 0.75 CYP2C9 (0.54) SMN1; SMN2ALDH1A1PPARAMEN1KMT2A
Propionic Acid SCHEMBL28830277 0.75 CYP2C9 (0.44) SMN1; SMN2ALDH1A1PPARAMEN1KMT2A
SCHEMBL12894351 0.75 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1PPARAMEN1KMT2A
SCHEMBL28001736 0.75 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1MEN1KMT2ACYP2C9
SCHEMBL7784387 0.75 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1MEN1KMT2ACYP2C9
SCHEMBL27403177 0.74 CYP2C9 (0.44) SMN1; SMN2ALDH1A1PPARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11358957-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2022-06-14 — — US disclosed
US-20200277287-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200277287-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES PRF1, NOX1, ARG2 SMN1; SMN2 2990/4885ALDH1A1 544/4885PPARA 733/4885
US-11358957-B2 Microbiocidal oxadiazole derivatives PRF1, NOX1, ARG2 SMN1; SMN2 2990/4885ALDH1A1 544/4885PPARA 733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback